JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2006) 189, 319-328    DOI: 10.1677/joe.1.06609
© 2006 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacRae, V E
Right arrow Articles by Ahmed, S F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacRae, V E
Right arrow Articles by Ahmed, S F

The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines

V E MacRae1,2, C Farquharson1 and S F Ahmed2

1 Bone Biology Group, Division of Gene Function and Development, Roslin Institute, Edinburgh EH25 9PS, UK
2 Bone and Endocrine Research Group, Royal Hospital for Sick Children, Glasgow G3 8SJ, UK

(Requests for offprints should be addressed to V E MacRae; vicky.macrae{at}bbsrc.ac.uk)

Childhood chronic inflammatory disease can be associated with transient and permanent growth retardation. This study examined the potential for spontaneous growth recovery following pro-inflammatory cytokine exposure. Murine ATDC5 chondrogenic cells and postnatal metatarsals were exposed to interleukin (IL)-1ß, IL-6 and tumour necrosis factor-{alpha} (TNF{alpha}), and their growth and proliferative capacity were determined following recovery. TNF{alpha} and IL-1ß reduced chondrocyte proliferation and aggrecan and collagen types II and X expression at minimum concentrations of 10 ng/ml and 0.1 ng/ml respectively. TNF{alpha} but not IL-1ß exposure led to increased caspase-3 activity and altered cellular morphology, consistent with reduced viability. Cytokine exposure particularly inhibited proteoglycan synthesis. This effect was dose and duration dependent. Compared with the control, IL-1ß and TNF{alpha} led to a 71% and 45% reduction in metatarsal growth after 8 days of exposure respectively (P < 0.05). An additive effect of IL-1ß combined with TNF{alpha} was observed (110% decrease; P < 0.05). Metatarsals exposed to IL-1ß or TNF{alpha} individually for a 2-day period, and allowed to recover spontaneously in the absence of cytokines for a further 6 days, showed normal growth trajectories. In combination, growth was 59% lower (P < 0.01) compared with control metatarsals at the end of the recovery period. Exposure to the combination for 4 days followed by a 4-day recovery period resulted in 87% decrement compared with controls (P < 0.05). IL-6 did not alter any parameter studied. IL-1ß and TNF{alpha} exert diverse inhibitory effects on ATDC5 chondrocyte dynamics and metatarsal growth. The extent of recovery following cytokine exposure depends on the duration of exposure, and may be incomplete following longer periods of exposure.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. Simon, A.-M. Prieur, P. Quartier, J. Charles Ruiz, and P. Czernichow
Early Recombinant Human Growth Hormone Treatment in Glucocorticoid-Treated Children with Juvenile Idiopathic Arthritis: A 3-Year Randomized Study
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2567 - 2573.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
V E MacRae, T Burdon, S F Ahmed, and C Farquharson
Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent.
J. Endocrinol., November 1, 2006; 191(2): 369 - 377.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Endocrinology.